FactaeThe Factual News

Abivax shares surge after positive results for obefazimod

French biotech firm Abivax has reported positive results for its experimental drug obefazimod.

Published 10sem1 sourceMajorupdated 3sem
Lire en français
≈ 15s

The fact

The company’s stock surged in trading following the announcement.

The data pertains to an ongoing clinical trial.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Paris · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on June 30, 2026
← Back to home
Discover

Read more

All marches →
marches30 %

Abivax plunges on stock market after safety concerns emerge on treatment

14sem · 1 sourcemarches800 million

Abivax raises $800 million and jumps 40% on the stock market

10sem · 1 sourcemarches

Biotech Abivax reaches milestone after record stock market year

18sem · 1 sourcemarches

Abivax releases positive results for an ulcerative colitis treatment

10sem · 1 sourcemarches0.8 %

CAC 40 declines in session, Abivax suspended after regulatory announcement

10sem · 1 source